The Europe Nephrostomy Devices Market would witness market growth of 7.6% CAGR during the forecast period (2019-2025). The prevalence of kidney stone disorder, increased requirement for minimally invasive surgical procedures, and risen awareness about the devices are some of the major factors that are influencing the market.
Nephrostomy is an opening that exists between the skin and the kidney. A nephrostomy tube that is passed from the back, is a thin plastic tube inserted through the skin, into the kidney, to the spot where urine is collected. The task of the tube is to drain the blocked urine. This enables the proper functioning of the kidney and protects it from further damage. Nephrostomy tubes help to clear out any infection. The entire procedure is guided by ultrasound and/or X-ray images (or pictures). Contrast has also injected the part of the kidney which collects urine. With this, the tube can easily drain the kidney to be inserted into the collecting system.
Based on Product, the market is segmented into Guidewires, Sheath Dilators, Nephrostomy Catheters, Drainage Tubes and Other Nephrostomy Devices. Based on End Use, the market is segmented into Hospital, Ambulatory Surgical Centers (ASCs) and Emergency Clinics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.
Market Segmentation:
By Product
By End Use
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 